The Dawn of Precision Medicine for Deep Brain Stimulation in Parkinson's Disease?
- PMID: 36103399
- DOI: 10.1002/mds.29224
The Dawn of Precision Medicine for Deep Brain Stimulation in Parkinson's Disease?
Comment on
-
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.Ann Neurol. 2022 Mar;91(3):424-435. doi: 10.1002/ana.26302. Epub 2022 Jan 25. Ann Neurol. 2022. PMID: 34984729 Free PMC article.
References
-
- Rothlind JC, York MK, Carlson K, et al. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry 2015;86(6):622-9.
-
- Yakufujiang M, Higuchi Y, Aoyagi K, et al. Predicting neurocognitive change after bilateral deep brain stimulation of subthalamic nucleus for Parkinson's disease. World Neurosurg 2021;147:e428-e436.
-
- Smeding HM, Speelman JD, Huizenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry 2011;82(7):754-760.
-
- Witt K, Daniels C, Krack P, et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease. J Neurol Sci 2011;310(1-2):261-266.
-
- Tröster AI, Jankovic J, Tagliati M, Peichel D, Okun MS. Neuropsychological outcomes from constant current deep brain stimulation for Parkinson's disease. Mov Disord 2017;32(3):433-440.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
